Current filters:  
New Zealand
New Zealand
Wynn Williams Lawyers
All non-essential businesses must close - where employees can work from home, they should do so and be paid accordingly.
Duncan Cotterill
The Biosecurity Act is to be reviewed partly as a result of flaws highlighted because of the Mycoplasma bovis outbreak.
Duncan Cotterill
If a NZ healthcare provider failed to follow this directive, the reputational and regulatory risks would be significant.
Duncan Cotterill
Preliminary findings are positive, but farmers must stay vigilant in farm biosecurity practices and NAIT record keeping.
Wynn Williams Lawyers
Despite criticism from some members of the public, the Bill addresses oral health problems currently facing New Zealand.
Duncan Cotterill
Pharmac is consulting on its proposed framework and for its new roles in funding hospital medicines and medical devices.
Duncan Cotterill
NZ has a first-class regulatory regime for food safety, as seen in the inquiry into Fonterra's Whey Protein Concentrate.
Duncan Cotterill
A Government inquiry into the whey protein concentrate contamination incident (the Fonterra Inquiry) has commenced.
Baldwins Intellectual Property
While Australia goes in to battle with tobacco companies, New Zealand makes its first move in the same direction.
James & Wells Intellectual Property
The Natural Health Products Bill paves the way for positive reform of the NZ natural health products industry.
James & Wells Intellectual Property
A regulatory authority will assess natural health products and impose penalties for breaches of new regulations.
James & Wells Intellectual Property
New legislation paves the way for positive reform of the New Zealand natural health products industry.
Chapman Tripp
Manufacturers, importers and distributors of natural health products will be subject to much tighter regulations.
Shelston IP
New Zealand's current Patents Act 1953 does not provide for a pharmaceutical extension of term – nor is such an extension proposed in the new Patents Bill 2008 which is presently before Parliament. However, with a US-NZ Free Trade Agreement imminent, things may be about to change.
DLA Piper Australia
The recent decision of the Court of Appeal has quashed the decision of the High Court which invalidated not only the decision of the Auckland Regional District Health Boards (ARDHBs) to award the contract to provide primary referred pathology services to Lab Tests but also the contract itself which was due to commence on 1 July 2007.
Minter Ellison Rudd Watts
The Therapeutic Goods Administration (TGA) has published a consultation paper seeking feedback on whether it should make excipient ingredients
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Font Size:
Mondaq Social Media